Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE

Corning Incorporated Acquires Axygen BioScience, Inc.

By Pharmaceutical Processing | September 16, 2009

Corning announced today that it has acquired all the shares of Axygen BioScience, Inc. and its subsidiaries from American Capital Ltd. for approximately $400 million in cash. Headquartered in Union City, Calif., Axygen is a leading manufacturer and distributor of high-quality life sciences plastic consumable labware, liquid handling products, and bench-top laboratory equipment with operations in the United States, France, Poland, and China. Axygen will be integrated into Corning’s Life Sciences segment. The acquisition supports Corning’s ongoing commitment to supply its customers with a comprehensive and innovative line of laboratory research products by extending its broad array of products. Axygen’s product portfolio of high-quality plastic consumables (including pipettes, pipette tips, and high-throughput screening (HTS) products) and lab equipment (including centrifuges, pipette controllers, and incubators) expands upon and complements the general labware, cell culture, and HTS/Assay products offered today by Corning. In addition, the acquisition enhances Corning’s presence in Asia through Axygen’s two manufacturing locations and increases access to customers in the Asia region. “Axygen’s product portfolio and established distribution network will significantly strengthen Corning’s life sciences platform and are critical components to our long-term growth strategy for this business,” said Peter F. Volanakis, Corning’s president and chief operating officer. “We believe this highly strategic acquisition offers synergies that will allow us to grow our life sciences business to more than $500 million in revenue by 2011,” he added. “We are looking forward to working with Axygen’s talented management team, whose leadership and vision have resulted in a set of brands recognized for quality and innovation by customers around the world,” said Mark A. Beck , senior vice president, Corning Life Sciences. Hemant Gupta, the founder of Axygen, will remain with the business, serving as president and chief executive officer, as will other key personnel of Axygen. Regarding this transaction, Gupta said, “We are very excited to be joining the Corning organization. Corning is a world leader in bringing innovative scientific labware products to market and we are looking forward to making major contributions to the continued success of this well-respected organization.”

Related Articles Read More >

These are the logos of Otsuka Medical and ICU Medical.
ICU Medical, Otsuka Pharmaceutical Factory launch joint IV supply chain venture
Amgen
Amgen to spend $900M to expand U.S. biopharma manufacturing
Roche
Roche to invest $50B in U.S. over next five years
Thermo Fisher Scientific
Thermo Fisher to invest $2B on U.S. manufacturing
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE